Tempus AI (NASDAQ:TEM) CFO James William Rogers Sells 7,257 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 7,257 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total transaction of $475,623.78. Following the transaction, the chief financial officer owned 131,216 shares of the company’s stock, valued at $8,599,896.64. This trade represents a 5.24% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tempus AI Price Performance

Shares of TEM opened at $67.91 on Friday. The firm has a market capitalization of $12.08 billion, a price-to-earnings ratio of -57.07 and a beta of 4.86. The firm’s fifty day simple moving average is $83.96 and its 200-day simple moving average is $71.87. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $104.32. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The firm had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. During the same quarter in the previous year, the firm posted ($0.46) earnings per share. The company’s revenue was up 84.7% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Tempus AI

Several institutional investors have recently added to or reduced their stakes in TEM. Victory Capital Management Inc. lifted its position in Tempus AI by 1.5% during the 3rd quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock worth $894,000 after acquiring an additional 162 shares during the period. Global Retirement Partners LLC raised its stake in shares of Tempus AI by 29.5% during the third quarter. Global Retirement Partners LLC now owns 733 shares of the company’s stock worth $59,000 after purchasing an additional 167 shares during the last quarter. US Bancorp DE raised its stake in shares of Tempus AI by 6.6% during the third quarter. US Bancorp DE now owns 2,848 shares of the company’s stock worth $230,000 after purchasing an additional 176 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its holdings in shares of Tempus AI by 0.7% during the second quarter. China Universal Asset Management Co. Ltd. now owns 33,757 shares of the company’s stock worth $2,145,000 after purchasing an additional 226 shares during the period. Finally, SeaCrest Wealth Management LLC grew its position in Tempus AI by 3.7% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 6,488 shares of the company’s stock valued at $524,000 after buying an additional 229 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on TEM shares. Morgan Stanley increased their price target on shares of Tempus AI from $68.00 to $80.00 and gave the company an “overweight” rating in a research note on Tuesday, November 11th. Needham & Company LLC increased their target price on shares of Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Canaccord Genuity Group decreased their price objective on shares of Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a research note on Wednesday, November 5th. Finally, Piper Sandler cut their target price on Tempus AI from $105.00 to $80.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $80.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.